Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease portfolio company news May 9 Written by MacDougall Creative MacDougall Creative https://www.macbiocom.com Previous Previous TScan Therapeutics Announces Pricing of $140 Million Public Offering Next Next Inspirna Appoints Dr. Usman “Oz” Azam, M.D., as New Chief Executive Officer
Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease portfolio company news May 9 Written by MacDougall Creative MacDougall Creative https://www.macbiocom.com
